authors: Mistry M, Zhukova N, Merico D, Rakopoulos P, Krishnatry R, Shago M, Stavropoulos
  J, Alon N, Pole JD, Ray PN, Navickiene V, Mangerel J, Remke M, Buczkowicz P, Ramaswamy
  V, Guerreiro Stucklin A, Li M, Young EJ, Zhang C, Castelo-Branco P, Bakry D, Laughlin
  S, Shlien A, Chan J, Ligon KL, Rutka JT, Dirks PB, Taylor MD, Greenberg M, Malkin
  D, Huang A, Bouffet E, Hawkins CE, Tabori U.
counts:
  biosamples: 18.0
  samples_acgh: 9.0
  samples_ccgh: 0.0
  samples_wes: 9.0
  samples_wgs: 0.0
geo_data:
  geo_json:
    coordinates:
    - -79.42
    - 43.7
    type: Point
  info:
    city: Toronto
    continent: ''
    country: Canada
    label: Toronto, Canada, North America
    precision: city
journal: J. Clin. Oncol. 33(9), 2015
notes: ''
pmid: '25667294'
title: BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of
  childhood secondary high-grade glioma.
year: '2015'
